{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:09:37Z","timestamp":1771564177233,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00676-3","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T03:14:33Z","timestamp":1766978073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design, synthesis, and integrated in silico analysis of novel difluoroboron curcumin analogues as potent inhibitors of the K562 leukemia cell line"],"prefix":"10.1007","volume":"40","author":[{"given":"Tahseen A.","family":"Alsalim","sequence":"first","affiliation":[]},{"given":"Hamsa H.","family":"Al-Hujaj","sequence":"additional","affiliation":[]},{"given":"Rehab G.","family":"Abood","sequence":"additional","affiliation":[]},{"given":"Ahmed A.","family":"Majed","sequence":"additional","affiliation":[]},{"given":"Aamal A.","family":"Al-Mutairi","sequence":"additional","affiliation":[]},{"given":"Magdi E. A.","family":"Zaki","sequence":"additional","affiliation":[]},{"given":"Sami A.","family":"Al-Hussain","sequence":"additional","affiliation":[]},{"given":"Sobhi M.","family":"Gomha","sequence":"additional","affiliation":[]},{"given":"Ahmed","family":"Elhenawy","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"3","key":"676_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA A. Cancer J Clin 71(3):209\u2013249","journal-title":"Cancer J Clin"},{"issue":"29","key":"676_CR2","first-page":"3661","volume":"31","author":"JR Carver","year":"2013","unstructured":"Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Ky B (2013) American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 31(29):3661\u20133675","journal-title":"J Clin Oncol"},{"key":"676_CR3","doi-asserted-by":"publisher","first-page":"142544","DOI":"10.1016\/j.molstruc.2025.142544","volume":"1340","author":"HH Al-Hujaj","year":"2025","unstructured":"Al-Hujaj HH, Majed AA, Qeaser RA, Dawood SA, Noor HF, Huda HN, Naser AN, Magdi EA, Sami Z, Sobhi AA, Anas MG, Ahmed A, Islam A\u2024E, M. A (2025) Thiazolidine derivatives as promising prostate cancer agents: design, synthesis, in vitro evaluation, DFT, ADME, POM, docking, and toxicity studies. J Mol Struct 1340:142544. https:\/\/doi.org\/10.1016\/j.molstruc.2025.142544","journal-title":"J Mol Struct"},{"issue":"3","key":"676_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83(3):770\u2013803","journal-title":"J Nat Prod"},{"issue":"4","key":"676_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4(4):253\u2013265","journal-title":"Nat Rev Cancer"},{"key":"676_CR6","doi-asserted-by":"publisher","unstructured":"Tahseen SFA, Hamid MSA, Ahmed AM, Mustafa HM, Eman S, Radwan A (2025) Synthesis, breast cancer activity, molecular docking and dynamic simulation of 1,4-Dihydropyridine derivatives. J Mol Struct 1321. https:\/\/doi.org\/10.1016\/j.molstruc.2024.139704","DOI":"10.1016\/j.molstruc.2024.139704"},{"issue":"4","key":"676_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"A Goel","year":"2008","unstructured":"Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as curecumin: from kitchen to clinic. Biochem Pharmacol 75(4):787\u2013809","journal-title":"Biochem Pharmacol"},{"key":"676_CR8","volume-title":"Herbal medicine: biomolecular and clinical aspects","author":"S Prasad","year":"2011","unstructured":"Prasad S, Aggarwal BB (2011) Turmeric, the golden spice: from traditional medicine to modern medicine. Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press\/Taylor & Francis, Boca Raton, FL","edition":"2"},{"issue":"5","key":"676_CR9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","volume":"60","author":"KM Nelson","year":"2017","unstructured":"Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA (2017) The essential medicinal chemistry of Curcumin. J Med Chem 60(5):1620\u20131637","journal-title":"J Med Chem"},{"issue":"1","key":"676_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","volume":"174","author":"T Ak","year":"2008","unstructured":"Ak T, G\u00fcl\u00e7in \u0130 (2008) Antioxidant and radical scavenging properties of Curcumin. Chem-Biol Interact 174(1):27\u201337","journal-title":"Chemico-Biol Interact"},{"issue":"42","key":"676_CR11","doi-asserted-by":"publisher","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","volume":"270","author":"S Singh","year":"1995","unstructured":"Singh S, Aggarwal BB (1995) Activation of transcription factor NF-kappa B is suppressed by Curcumin (diferuloylmethane). J Biol Chem 270(42):24995\u201325000","journal-title":"J Biol Chem"},{"issue":"3","key":"676_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1208\/s12248-009-9128-x","volume":"11","author":"J Ravindran","year":"2009","unstructured":"Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11(3):495\u2013510","journal-title":"AAPS J"},{"issue":"1","key":"676_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2008.03.025","volume":"267","author":"P Anand","year":"2008","unstructured":"Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008) Curcumin and cancer: an old-age disease with an age-old solution. Cancer Lett 267(1):133\u2013164","journal-title":"Cancer Lett"},{"key":"676_CR14","unstructured":"Bachmeier B, Killian P, Pfeffer U, Iancu C (2007) Novel aspects of curcumin in cancer prevention. BioFactors, 29(2\u20133), pp. 75\u201385"},{"issue":"1A","key":"676_CR15","first-page":"363","volume":"23","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363\u2013398","journal-title":"Anticancer Res"},{"key":"676_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6882-6-10","volume":"6","author":"CD Lao","year":"2006","unstructured":"Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, Brenner DE (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"676_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807\u2013818","journal-title":"Mol Pharm"},{"issue":"04","key":"676_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-2006-957450","volume":"64","author":"G Shoba","year":"1998","unstructured":"Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998) Influence of Piperine on the pharmacokinetics of Curcumin in animals and human volunteers. Planta Med 64(04):353\u2013356","journal-title":"Planta Med"},{"issue":"4","key":"676_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","volume":"27","author":"MH Pan","year":"1999","unstructured":"Pan MH, Huang TM, Lin JK (1999) Biotransformation of Curcumin through reduction and conjugation in mice. Drug Metab Dispos 27(4):486\u2013494","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"676_CR20","first-page":"2342","volume":"64","author":"DG Brown","year":"2020","unstructured":"Brown DG, Wobst HJ (2020) A decade of FDA-approved drugs (2010\u20132019): trends and perspectives. J Med Chem 64(5):2342\u20132361","journal-title":"J Med Chem"},{"key":"676_CR21","doi-asserted-by":"publisher","first-page":"100384","DOI":"10.1016\/j.jphotochemrev.2020.100384","volume":"45","author":"LD Dias","year":"2020","unstructured":"Dias LD et al (2020) Curcumin as a photosensitizer: from molecular structure to recent advances in antimicrobial photodynamic therapy. J Photochem Photobiol C 45:100384","journal-title":"J Photochem Photobiol C"},{"issue":"8","key":"676_CR22","doi-asserted-by":"publisher","first-page":"e2000171","DOI":"10.1002\/cbdv.202000171","volume":"17","author":"D Zheng","year":"2020","unstructured":"Zheng D et al (2020) Antibacterial mechanism of curcumin: a review. Chem Biodivers 17(8):e2000171","journal-title":"Chem Biodivers"},{"issue":"16","key":"676_CR23","first-page":"4495","volume":"45","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC (2016) Degradable Boron-Based materials for biomedical applications. Chem Soc Rev 45(16):4495\u20134509","journal-title":"Chem Soc Rev"},{"issue":"30","key":"676_CR24","first-page":"14935","volume":"22","author":"V Leen","year":"2012","unstructured":"Leen V, Yuan P, Wang L, Boens N (2012) Curcumin-BODIPY-based ratiometric fluorescent chemosensors. J Mater Chem 22(30):14935\u201314945","journal-title":"J Mater Chem"},{"issue":"9584","key":"676_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","volume":"370","author":"R Hehlmann","year":"2007","unstructured":"Hehlmann R, Hochhaus A, Baccarani M (2007) Chronic myeloid leukaemia. Lancet 370(9584):342\u2013350","journal-title":"Lancet"},{"issue":"10","key":"676_CR26","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96(10):3343\u20133356","journal-title":"Blood"},{"issue":"3","key":"676_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45(3):321\u2013334","journal-title":"Blood"},{"issue":"3","key":"676_CR28","first-page":"262","volume":"73","author":"E Venkata Rao","year":"2011","unstructured":"VENKATA RAO* E (2011) Revisiting Curcumin chemistry part I: a new strategy for the synthesis of curcuminoids. Indian J Pharm Sci 73(3):262\u2013270","journal-title":"Indian J Pharm Sci"},{"key":"676_CR29","doi-asserted-by":"publisher","unstructured":"Cao Y, Balduf T, Beachy MD, Bennett MC, Bochevarov AD, Chien A, Dub PA, Dyall KG, Furness JW, Halls MD, Hughes TF, Jacobson LD, Kwak HS, Levine DS, Mainz DT, Moore KB, Svensson M, Videla PE, Watson MA, Friesner RA (2024) Quantum chemical package jaguar: a survey of recent developments and unique features. J Chem Phys 161(5). https:\/\/doi.org\/10.1063\/5.0213317","DOI":"10.1063\/5.0213317"},{"key":"676_CR30","doi-asserted-by":"publisher","first-page":"154104","DOI":"10.1063\/1.3382344","volume":"132","author":"S Grimme","year":"2010","unstructured":"Grimme S, Antony J, Ehrlich S, Krieg H (2010) A consistent and accurate Ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J Chem Phys 132:154104","journal-title":"J Chem Phys"},{"key":"676_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"676_CR32","first-page":"2747","volume":"27","author":"JR L\u00f3pez-Blanco","year":"2011","unstructured":"L\u00f3pez-Blanco JR, Garz\u00f3n JI, Chac\u00f3n P (2011) iMODS: a web server to analyze and visualize protein normal-mode-based mobility. Bioinformatics 27:2747\u20132748","journal-title":"Bioinformatics"},{"issue":"4","key":"676_CR33","first-page":"2173","volume":"64","author":"G Rehab","year":"2021","unstructured":"Rehab G, Abood TA, Alsalim, Einas A, Abood (2021) Design and synthesis of new curcuminoid compounds and their derivatives as antioxidant agents. Egypt J Chem Vol 64(4):2173\u20132183","journal-title":"Egypt J Chem Vol"},{"key":"676_CR34","doi-asserted-by":"crossref","unstructured":"a) Ooko E, Alsalim T, Saeed B, Saeed MEM, Kadioglu O, Abbo HS, Titinchi SJJ, Efferth T Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. (2016) 305, 216. https:\/\/doi.org\/10.1016\/j.taap.2016.06.002. b) Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4, 807","DOI":"10.1016\/j.taap.2016.06.002"},{"key":"676_CR35","doi-asserted-by":"publisher","unstructured":"a) G\u00e1l E, Nagy LC Photophysical Properties and Electronic Structure of Symmetrical Curcumin Analogues and Their BF (2021) 13, 2299. https:\/\/doi.org\/10.3390\/sym13122299. b) Sui, Z.; Salto, R.; Li, J.; Craik, C.; Ortiz de Montellano, P.R. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg. Med. Chem. 1993, 1, 415\u2013422","DOI":"10.3390\/sym13122299"},{"key":"676_CR36","doi-asserted-by":"publisher","first-page":"102313","DOI":"10.1016\/j.rechem.2025.102313","volume":"16","author":"MG Badrey","year":"2025","unstructured":"Badrey MG, Elhenawy AA, Alam MM, Nazreen S, Zaki MEA, Gomha SM (2025) Novel imidazoles from guanylhydrazone: synthesis, computational, and molecular Docking studies as \u03b1-amylase inhibitors for type 2 diabetes management. Results Chem 16:102313. https:\/\/doi.org\/10.1016\/j.rechem.2025.102313","journal-title":"Results Chem"},{"key":"676_CR37","doi-asserted-by":"publisher","first-page":"108314","DOI":"10.1016\/j.bioorg.2025.108314","volume":"158","author":"MH Helal","year":"2025","unstructured":"Helal MH, Alsehli MH, Al-Dies A-AM, Moussa Z, Elgammal WE, Halawa AH, Elhenawy AA, El-Agrody AM (2025) Unraveling the interaction of pyranocoumarins with P-glycoprotein: implications for overcoming multidrug resistance in cancer therapy. Bioorg Chem 158:108314\u2013108314. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108314","journal-title":"Bioorg Chem"},{"issue":"7","key":"676_CR38","doi-asserted-by":"publisher","first-page":"p1257","DOI":"10.3390\/molecules24071257","volume":"24","author":"C Pozzi","year":"2019","unstructured":"Pozzi C, Ferrari S, Luciani R, Tassone G, Costi MP, Mangani S (2019) Structural comparison of Enterococcus faecalis and human thymidylate synthase complexes with the substrate dUMP and its analogue FdUMP provides hints about enzyme conformational variabilities. Molecules 24(7):p1257. https:\/\/doi.org\/10.3390\/molecules24071257","journal-title":"Molecules"},{"key":"676_CR39","doi-asserted-by":"publisher","first-page":"108771","DOI":"10.1016\/j.abb.2021.108771","volume":"700","author":"RU Savale","year":"2021","unstructured":"Savale RU, Bhowmick S, Osman SM, Alasmary FA, Almutairi TM, Abdullah DS, Patil PC, Islam MA (2021) Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV- 2 Inhibition. Arch Biochem Biophys 700:108771","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"676_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337\u2013341","journal-title":"Drug Discov Today Technol"},{"key":"676_CR41","doi-asserted-by":"crossref","unstructured":"Mohapatra RK, Perekhoda L, Azam M, Suleiman M, Sarangi AK, Semenets A, Pintilie L, Al-Resayes SI (2021) Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in Silico toxicity analysis. J King Saud Univ \u2013 Sci 33 (2), 101315,]","DOI":"10.1016\/j.jksus.2020.101315"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00676-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T03:14:35Z","timestamp":1766978075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00676-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00676-3","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"28"}}